Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?

Algan, O; Pinover, W H; Hanlon, A L; Al-Saleem, T I; Hanks, G E

Algan, O; Pinover, W H; Hanlon, A L; Al-Saleem, T I; Hanks, G E.

Affiliation

Algan O; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. oalgan@azcc.arizona.edu

Radiat Oncol Investig ; 7(2): 106-10, 1999.

Article in En | MEDLINE | ID: mdl-10333251

Subject(s)

Carcinoma/radiotherapy; Prostate-Specific Antigen/blood; Prostatic Neoplasms/radiotherapy; Radiotherapy, Conformal; Aged; Aged, 80 and over; Biomarkers, Tumor/blood; Carcinoma/blood; Carcinoma/pathology; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms/blood; Prostatic Neoplasms/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Carcinoma / Prostate-Specific Antigen / Radiotherapy, Conformal Type of study: Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Radiat Oncol Investig Year: 1999 Document type: Article

Search on Google

XML

PubMed Links